| Vignola Mark J. |
Chief Financial Officer |
Terns Pharmaceuticals, Inc. (TERN)
|
2024-05-31 |
$4.44 |
68.0% |
4,791
|
$21,272 |
| Vignola Mark J. |
Chief Financial Officer |
Terns Pharmaceuticals, Inc. (TERN)
|
2023-11-30 |
$3.78 |
97.4% |
743
|
$2,809 |
| Vignola Mark J. |
Chief Financial Officer |
Terns Pharmaceuticals, Inc. (TERN)
|
2023-05-31 |
$1.41 |
429.1% |
9,997
|
$14,096 |
| Vignola Mark J. |
Chief Financial Officer |
Terns Pharmaceuticals, Inc. (TERN)
|
2022-11-30 |
$1.41 |
429.1% |
3
|
$4 |
| Vignola Mark J. |
Chief Financial Officer |
Terns Pharmaceuticals, Inc. (TERN)
|
2022-05-31 |
$1.47 |
407.5% |
7,656
|
$11,254 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
249.9% |
$123,563 |
$49,435 |